SCHEMBL17469504

SCHEMBL17469504

CNCCN(C)Cc1n[nH]c2ccc(OC)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 6/20 0.44
▸ PRMT1 Q99873 2/20 0.43
▸ HTR2C P28335 5/20 0.41
▸ HTR2B P41595 4/20 0.41
▸ HTR6 P50406 4/20 0.41
▸ FADS1 O60427 1/20 0.40
▸ HTR1A P08908 3/20 0.39
▸ HTR1D P28221 3/20 0.39
▸ HTR1E P28566 3/20 0.39
▸ HTR7 P34969 3/20 0.39
▸ HTR5A P47898 3/20 0.39
▸ MTNR1B P49286 3/20 0.39
▸ MTNR1A P48039 2/20 0.39
▸ HTR3E A5X5Y0 1/20 0.39
▸ HTR3B O95264 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HTR1B P28222 1/20 0.39
▸ HTR1F P30939 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17469509 0.93 PRMT1 (0.43) HTR2APRMT1HTR2CHTR2BHTR6
SCHEMBL17469445 0.92 FADS1 (0.40) HTR2APRMT1HTR2CHTR2BHTR6
SCHEMBL17469471 0.88 TTK (0.48) PRMT1KDM4EMEN1ALDH1A1TSHR
SCHEMBL16100514 0.88 LRRK2 (0.43) LRRK2
SCHEMBL17469452 0.87 PRMT1 (0.47) PRMT1LRRK2
SCHEMBL17469469 0.87 PRMT5 (0.37) PRMT1HTR6L3MBTL1ALDH1A1LRRK2
SCHEMBL16129433 0.87 LRRK2 (0.38) PRMT1KDM4EALDH1A1HSD17B10LRRK2
SCHEMBL17469449 0.86 PRMT1 (0.37) HTR2APRMT1CYP2C9KDM4EALDH1A1
SCHEMBL16120045 0.86 TTK (0.39) PRMT1HTR6HTR1DHTR1BKDM4E
SCHEMBL17469484 0.86 TTK (0.39) PRMT1HTR1AHTR1DHTR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2018-04-19 — — US disclosed
US-9765035-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-09-19 — — US disclosed
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 HTR2A 4184/4885PRMT1 1/4885HTR2C 4427/4885
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 HTR2A 4184/4885PRMT1 1/4885HTR2C 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback